Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr
about
Molecular Imaging of Biomarkers in Breast CancerDevelopment of Companion DiagnosticsMolecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerQuantitative Evaluation of Therapeutic Response by FDG-PET-CT in Metastatic Breast Cancer¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.Pigmentation of the Tongue with Lapatinib Treatment in a Patient with Advanced Breast Cancer: A Case Report.Molecular Imaging in Oncology Using Positron Emission Tomography.Early prediction of lenvatinib treatment efficacy by using F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational stud
P2860
Q26772870-AA198545-257A-4E59-A54B-E336D7C4D0D1Q26774670-D0301797-C79C-4A5A-9432-793D2159C074Q28072513-DA60C9DB-7524-4451-ABF2-6213D29A755DQ36883389-01101A88-8FA0-4FBC-B13C-0EF37F1F4A0CQ37582345-C50AC050-F02A-4C75-B8CE-5651755F9CE6Q40319145-B95D10B9-2594-4E20-A9C7-91785636DCD0Q55182174-F743FAB4-4BA1-42BE-8053-19230C0F09C1Q56515680-FD1F1535-551B-4D4C-9B54-D01E9EBE56FD
P2860
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@ast
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@en
type
label
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@ast
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@en
prefLabel
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@ast
Phase II Study of Lapatinib in ...... ucose Positron Emission Tomogr
@en
P2093
P2860
P356
P1476
Phase II Study of Lapatinib in ...... Tomography Imaging (TBCRC 003)
@en
P2093
Andrea L Richardson
Annick D Van den Abbeele
Carla I Falkson
Carlos L Arteaga
E Claire Dees
Eric P Winer
Ian E Krop
Ingrid A Mayer
Julie S Najita
P2860
P304
P356
10.1200/JCO.2014.60.0353
P407
P577
2015-07-13T00:00:00Z